Thankyou for replying, but I feel you are reinforcing the dichotomy I described: you are saying because it is effective in one dimension (eg. reducing deaths)

Thankyou for replying, but I feel you are reinforcing the dichotomy I described: you are saying because it is effective in one dimension (eg. reducing deaths), we should live with any inadequacies. There is certainly an incentive to make a mostly safe and effective vaccine, but what incentive is there to make the best one possible? Especially when they are given complete indemnity for their decisions, and walking through preopened gates of government approvals. I feel there is a big moral hazard here that we just hand-wave away.